Related Experiment Video
Updated: May 7, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Insights into AT1 receptor activation through AngII binding studies
Minos-Timotheos Matsoukas1, Constantinos Potamitis, Panayiotis Plotas
1Laboratori de Medicina Computacional, Unitat de Bioestadıstica, Facultat de Medicina, Universitat Autonoma de Barcelona , E-08193, Bellaterra, Barcelona, Spain.
This study details angiotensin II (AngII) binding to its type 1 receptor (AT1R) using molecular dynamics simulations. It reveals key interactions and structural changes during receptor activation, offering a complete binding profile.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- G-protein-coupled receptors (GPCRs) mediate cellular responses to various stimuli.
- The angiotensin II type 1 receptor (AT1R) is a key GPCR involved in cardiovascular regulation.
- Understanding ligand-receptor interactions is crucial for drug development.
Purpose of the Study:
- To investigate the binding profile of angiotensin II (AngII) to the angiotensin II type 1 receptor (AT1R).
- To elucidate the crucial interactions governing AngII binding and AT1R activation.
- To simulate and analyze the structural rearrangements of AT1R upon activation.
Main Methods:
- Molecular dynamics (MD) simulations of the AT1R-AngII-lipids complex.
- Utilizing AngII conformations from Nuclear Magnetic Resonance (NMR) data (ROEs).
- Employing in silico flexible docking methodologies.
Main Results:
- Observed dynamic changes in AngII topology and the intracellular receptor domain during simulations.
- Identified key transitional elements of the AT1R and AngII during activation.
- Characterized the complete binding profile of AngII to AT1R.
Conclusions:
- The study provides a comprehensive understanding of AngII binding to AT1R.
- Key structural dynamics and transitional elements involved in AT1R activation were identified.
- NMR and in silico approaches successfully elucidated the activation mechanism.
More Related Videos
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...